WEBVTT 1 00:00:08.057 --> 00:00:17.402 We are an insurance distribution company, listed on the Australian stock exchange and we have a number of interesting 2 00:00:17.403 --> 00:00:26.749 businesses mainly in Australia, but also branching offshore into New Zealand, Singapore, London and into Europe. 3 00:00:26.750 --> 00:00:36.096 The consolidation tool that we originally selected had a use-by life which is coming up very shortly so we chose to look 4 00:00:36.097 --> 00:00:45.442 at the market again, and look to the number of alternatives, and CCH Tagetik was far and away the number one choice for us to move into. 5 00:00:45.443 --> 00:00:54.789 We were with SAP on their BPC program. The BPC tool had most of the capability we needed on the consolidation 6 00:00:54.790 --> 00:01:04.136 but it really struggled to go beyond what I would call the statutory process and actually give us that management 7 00:01:04.137 --> 00:01:13.482 slicing and dicing of the data. So we often had to take data to Excel to re-reconcile it, to dive into those insights. 8 00:01:13.483 --> 00:01:22.829 So what we're looking at with CCH Tagetik is to have all that functionality put in together as one. What I was really looking for beyond that, was the innovation phase, 9 00:01:22.830 --> 00:01:32.176 or the ability to go beyond, to have that flexibility and structure to cope with whatever problem we want to throw at it and also then look to the future 10 00:01:32.177 --> 00:01:41.522 so that we knew we could grow and build with it. I always saw it has been a product that had far more 11 00:01:41.523 --> 00:01:50.869 capability than I ever needed it to have. And the fact that it actually has produced the core functionality but allows us to go further means I would have to 12 00:01:50.870 --> 00:02:00.216 recommend it to anybody else who is looking at it. I think it's a really good value-for-money proposition with a very long life within a company that 13 00:02:00.217 --> 00:02:09.550 will emerge to take over the market as the dominant player.